After Pfizer, Serum Institute seeks indemnity over COVID-19 vaccine: Sources
New Delhi: Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute...
Mehul Choksi fit to be deported to India, onus lies on Dominican court: Ex...
New Delhi: Fugitive diamantaire Mehul Choksi being held in police custody in Dominica, is fit to be deported to India according to former Central...
Bitcoin, Ethereum, DOGE: Top Crypto Prices Today
New Delhi: The cryptocurrency market has been turbulent for two weeks now starting the meltdown on May 19 leading to a tremendous decrease in...
Canara Bank to raise Rs 9,000 crore via Equity and Debt Instruments
New Delhi: Canara Bank, the leading nationalized bank, in its Board of Directors meeting, held today i.e. 28.05.2021, has approved the Capital Raising Plan...
Sitharaman to chair 43rd GST Council meeting today
New Delhi: Union Finance Minister Nirmala Sitharaman is scheduled to chair the 43rd Goods and Services Tax (GST) Council meeting through video conferencing on...
Bitcoin recovers to $35k after dipping more than 14% on Sunday
New Delhi: Bitcoin once again crossed the mark of $35,000 on Monday after sliding by more than 14% on the weekend. The overall decline...
Top 5 Cryptocurrency to invest in India now: Check price predictions
New Delhi: Investors are once again buying the cryptocurrency after Elon Musk showed his support for the ‘new finance’. Right now, there are more...
Wanna invest in crypto? Beware of the fake trading apps and exchanges
New Delhi: UK based security software and hardware company, Sophos recently identified over 150 fraudulent Android and iOS apps who intend to rob financial...
Covid-19 Vaccine: Dr Reddy’s rolls out Sputnik V in India at around Rs 995...
New Delhi: Dr. Reddy’s Laboratories on Friday has said that Russia’s Sputnik V COVID-19 vaccine have been priced at Rs 948 + 5 percent...
DGCI approves Phase 2/3 clinical trials of COVAXIN for 2-18 years old
New Delhi: Drugs Controller General of India (DGCI) approved the Phase 2 and 3 clinical trials of the COVAXIN which was made by Indian...
